The Efficacy and Safety of Rituximab for the Treatment of Pediatric Autoimmune Neuroinflammatory Disorders at a Single Center

Purpose Rituximab is increasingly used as a second-line treatment of neuroinflammatory disorders to improve clinical outcomes in cases refractory to conventional immunotherapy and to reduce relapses. This study aimed to demonstrate the efficacy and safety of rituximab used for pediatric autoimmune n...

Descripció completa

Dades bibliogràfiques

Autors principals:	Young Jun Ko, Young Kyu Shim, Woo Joong Kim, Soo Yeon Kim, Hunmin Kim, Hee Hwang, Jong-Hee Chae, Ji Eun Choi, Ki Joong Kim, Byung Chan Lim
Format:	Artigo
Idioma:	Inglês
Publicat:	Korean Child Neurology Society 2020-01-01
Col·lecció:	Annals of Child Neurology
Matèries:	rituximab anti-n-methyl-d-aspartate receptor encephalitis opsoclonus-myoclonus syndrome neuromyelitis optica
Accés en línia:	http://www.annchildneurol.org/upload/pdf/acn-2019-00290.pdf
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!